Alamar Biosciences
(NASDAQ) ALMR
Alamar Biosciences Financials at a Glance
Market Cap
$1.97BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Revenue (TTM)
$39.13
Net Income (TTM)
-$28.98
EPS (TTM)
$0.00
P/E Ratio
0.00
Dividend
$0.00
Beta (Volatility)
1.53 (High)
Dividend
$0.00
Beta (Volatility)
1.53 (High)
Price
$28.47
Volume
246,959.547
Open
$26.48
Price
$28.47
Volume
246,959.547
Open
$26.48
Previous Close
$28.42
Daily Range
$26.01 - $28.49
52-Week Range
$17.00 - $28.68
Estimated Earnings Date
Aug 14, 2026
Dividend
$0.00
Beta (Volatility)
1.53 (High)
Price
$28.47
Volume
246,959.547
Open
$26.48
Previous Close
$28.42
Daily Range
$26.01 - $28.49
52-Week Range
$17.00 - $28.68
Estimated Earnings Date
Aug 14, 2026
ALMR News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Alamar Biosciences
Industry
Life Sciences Tools and Services
Sector
Health CareEmployees
250
CEO
Yu Ling Luo, PhD
Website
www.alamarbio.comHeadquarters
Fremont, CA 94538, US
ALMR Financials
Key Financial Metrics (TTM)
Gross Margin
56.20%
Operating Margin
-42.22%
Net Income Margin
-40.18%
Return on Equity
18.76%
Return on Capital
N/A
Return on Assets
-21.30%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$1.97BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Shares Outstanding
69.31M
Volume
246.96K
Avg. Volume
396.66K
Financials (TTM)
Gross Profit
$14.46M
Operating Income
-$12.35M
EBITDA
-$19.47M
Operating Cash Flow
-$20.35M
Capital Expenditure
-$600.00K
Free Cash Flow
-$20.95M
Cash & ST Invst.
$64.59M
Total Debt
$340.55M
Alamar Biosciences Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$26.04M
N/A
Gross Profit
$14.46M
N/A
Gross Margin
55.53%
N/A
Market Cap
$1.97BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
N/A
Market Cap/Employee
$8.87M
N/A
Employees
222
N/A
Net Income
-$21.33M
N/A
EBITDA
-$19.47M
N/A
Quarterly Fundamentals
Total Cash
$64.59M
N/A
Total Debt
$340.55M
N/A
Accounts Receivable
$19.52M
N/A
Inventory
$39.93M
N/A
Long Term Debt
$338.95M
N/A
Short Term Debt
$1.60M
N/A
Return on Assets
-21.30%
N/A
Return on Invested Capital
-26.95%
N/A
Free Cash Flow
-$20.95M
N/A
Operating Cash Flow
-$20.35M
N/A